Silina, L.; Dufour, F.; Rapinat, A.; Reyes, C.; Gentien, D.; Maksut, F.; Radvanyi, F.; Verrelle, P.; Bernard-Pierrot, I.; Mégnin-Chanet, F.
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation. Int. J. Mol. Sci. 2022, 23, 8671.
https://doi.org/10.3390/ijms23158671
AMA Style
Silina L, Dufour F, Rapinat A, Reyes C, Gentien D, Maksut F, Radvanyi F, Verrelle P, Bernard-Pierrot I, Mégnin-Chanet F.
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation. International Journal of Molecular Sciences. 2022; 23(15):8671.
https://doi.org/10.3390/ijms23158671
Chicago/Turabian Style
Silina, Linda, Florent Dufour, Audrey Rapinat, Cécile Reyes, David Gentien, Fatlinda Maksut, François Radvanyi, Pierre Verrelle, Isabelle Bernard-Pierrot, and Frédérique Mégnin-Chanet.
2022. "Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation" International Journal of Molecular Sciences 23, no. 15: 8671.
https://doi.org/10.3390/ijms23158671
APA Style
Silina, L., Dufour, F., Rapinat, A., Reyes, C., Gentien, D., Maksut, F., Radvanyi, F., Verrelle, P., Bernard-Pierrot, I., & Mégnin-Chanet, F.
(2022). Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation. International Journal of Molecular Sciences, 23(15), 8671.
https://doi.org/10.3390/ijms23158671
